Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant

NCT00114777 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

595

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Cyclosporin A
DRUG: Belatacept Less Intensive Regimen (LI)
DRUG: Belatacept More Intensive Regimen (MI)

Sponsor

Bristol-Myers Squibb